News FDA issues summary of grants, promotes rare disease research The US Food and Drug Administration (FDA) has provided an ‘at-a-glance’ summary of the agency’s news.
News After rebuffing Biogen, Sage pairs off with Supernus Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
